Back to search

Article

Fundamental Considerations for GeneticallyGuided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms

2018-11-14

Abstract excerpt

Background: A major challenge for effective pharmacotherapy in pain management is to provide the drug best suited to the patient’s innate characteristics. Objective: The article illustrates pharmacogenetic principles to optimize treatments for patients and increase the likelihood of pain relief without dependence. Genetic variances are particularly relevant to opioid drugs used in pain control, and can now be harv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fc162d67-ffc0-5cd4-b469-842c02ba6a37
DOI
10.36076/ppj.2018.6.e611
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fundamental Considerations for GeneticallyGuided Pain Management with Opioids Based on CYP2D6 and OPRM1 PolymorphismsDOI 10.36076/ppj.2018.6.e611
Select a neighboring publication to make it the new centre.